Exploring the hidden danger of noncardiac drugs

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 10, 1998, Pages 1114-1116

  Priori, S G ^a  

^a IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; CISAPRIDE; CYTOCHROME P450; ERYTHROMYCIN; KETOCONAZOLE; LORATADINE; NON PRESCRIPTION DRUG; POTASSIUM CHANNEL BLOCKING AGENT; TERFENADINE;

DATA BASE; DRUG ACTIVITY; DRUG INDUCED DISEASE; EDITORIAL; ELECTROCARDIOGRAM; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; REPOLARIZATION; SCREENING TEST; TORSADE DES POINTES; TREATMENT INDICATION;

EID: 0031786767     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00889.x     Document Type: Editorial

References (12)

1. 1 Fuhr U: Drug interactions with grapefruit: Extent probable mechanism and clinical relevance. Drug Saf 1998 ; 18: 251–272.
2. 2 Vitola J, Vukanovic J, Roden D: Cisapride‐induced torsades de pointes. J Cardiovasc Electrophysiol 1998 ; 9 (10): 5.
3. 3 Sanguinetti MC, Jiang C, Durran ME, et al: A mechanistic link between inherited and acquired cardiac arrhythmia: HERG encodes the Ikr potassium channel. Cell 1995 ; 81: 1–20.
4. 4 Honig PK, Wortham DC, Zamani K, et al: Terfenadine‐ketoconazole interaction: Pharmacokinetic and electrocardiographic consequences. JAMA 1993 ; 269: 1513–1518.
5. 5 Moss AJ, Schwartz PJ, Crampton RS, et al: The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991 ; 84: 1136–1144.
6. 6 Liu XK, Katchman A, Drici MD, et al: Gender difference in the cycle length‐dependent QT and potassium currents in rabbits. J Pharmacol Exp Ther 1998 ; 285: 672–679.
7. 7 Taglialatela M, Castaldo P, Iossa S, et al: Regulation of the human ether‐a‐gogo related gene (HERG) K+ channel by reactive oxygen species. Proc Natl Acad Sci U S A 1997 ; 94: 11698–11703.
8. 8 Sanguinetti MC, Jurkiewicz NK: Role of external Ca2+ and K+ in gating of cardiac delayed rectifier K+ currents. Pflügers Arch 1992 ; 420: 180–186.
9. 9 Compton SJ, Lux RL, Ramsey MR, et al: Genetically defined therapy of inherited long‐QT syndrome. Correction of abnormal repolarization by potassium. Circulation 1996 ; 94 (5): 1018–1022.
10. 10 Napolitano C, Priori SG, Schwartz PJ, et al: Identification of a long QT syndrome molecular defect in druginduced torsades de pointes. (Abstract) Circulation 1997 ; 96: I–211.
11. 11 Schultz‐Bahr E, Haverkamp W, Hordt M, et al: Do mutations in cardiac ion channel genes predispose to drug‐induced (acquired) long QT syndrome ? (Abstract) Circulation 1997 ; 96: I–211.
12. 12 Gonzalez FJ, Idle JR: Pharmacogenetic phenotyping and genotyping. Present status and future potential. Clin Pharmacokinet 1994 ; 16: 59–70.